NT5E (CD73) as a prognostic biomarker and therapeutic target associated with immune infiltration in lung adenocarcinoma
Abstract Lung adenocarcinoma (LUAD), the most common type of lung cancer, is a leading cause of cancer-related mortality. NT5E, an ecto-5’-nucleotidase enzyme, has been implicated in cancer progression, particularly in efferocytosis. Despite its potential involvement, the prognostic significance of...
Saved in:
Main Authors: | Leyan Chen, Tuoya Qi, Bishu Zhang, Xuelong Wang, Mingfeng Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-88964-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of LMNB2 as a diagnostic and prognostic biomarker in lung adenocarcinoma
by: Shengshan Xu, et al.
Published: (2025-02-01) -
NIPAL1 as a prognostic biomarker associated with pancreatic adenocarcinoma progression and immune infiltration
by: Youlong Zhu, et al.
Published: (2025-01-01) -
CHST1 as a prognostic-related biomarker in gastric cancer correlating with immune infiltration
by: Long Gui, et al.
Published: (2025-02-01) -
EXO1 is a key gene for lung-resident memory T cells and has diagnostic and predictive values for lung adenocarcinoma
by: Zhuoqi Li, et al.
Published: (2025-02-01) -
Development and functional validation of a disulfidoptosis-related gene prognostic model for lung adenocarcinoma based on bioinformatics and experimental validation
by: Tao Shen, et al.
Published: (2025-02-01)